Biotechnology firm Genzyme Corp. said Thursday that it was buying Ilex Oncology Inc. for $1 billion in stock to bolster its business of providing drugs to treat cancer. Genzyme, based in Cambridge ...

French drug maker Sanofi-Aventis SA has agreed to buy Genzyme Corp. in a sweetened all-cash $20.1 billion deal that ends months of corporate haggling and positions Sanofi at the forefront of the ...

French drugmaker Sanofi-Aventis SA clinched its long-sought deal for Genzyme Corp with a sweetened $20.1 billion cash offer, plus payments tied to the success of the U.S. biotech group's drugs.

Lunchtime has not been the same the last few months for Therese Sliwa, an executive assistant at Genzyme Corp. Instead of sitting at her desk eating something of questionable nutritional value ...

Genzyme Corp. will be paying a settlement to resolve allegations that it inappropriately marketed a surgical device. Cambridge-based biotech Genzyme Corp. will be paying a $32.5 million settlement ...

Genzyme Corp.'s fourth-quarter earnings dropped 73% because of manufacturing problems that the maker of rare-disease treatments expects to continue to hurt earnings this year. The Cambridge, Mass ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Genzyme Corporation (Nasdaq: GENZ) announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine) in combination with the chemotherapy ...

Genzyme Corp. said it would spend $325 million up front in a licensing and investment pact with Isis Pharmaceuticals Inc., securing partial rights to a promising cholesterol-lowering drug that ...

NEW YORK (MarketWatch) -- Genzyme Corp. Tuesday said it's increasing its proposal to acquire AnorMED Inc. to $580 million, or $13.50 per share. The bid represents an effort by Genzyme to trump the ...

SAN FRANCISCO (CBS.MW) -- Genzyme Corp. said Tuesday that fourth-quarter revenue rose 23 percent following completion of two mergers, approval of Clolar, and the purchase of U.S. sales and ...